311 related articles for article (PubMed ID: 27448118)
1. Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer.
Warren LE; Ligibel JA; Chen YH; Truong L; Catalano PJ; Bellon JR
Ann Surg Oncol; 2016 Nov; 23(12):3870-3879. PubMed ID: 27448118
[TBL] [Abstract][Full Text] [Related]
2. Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer.
Bergom C; Kelly T; Bedi M; Saeed H; Prior P; Rein LE; Szabo A; Wilson JF; Currey AD; White J
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):65-71. PubMed ID: 27511848
[TBL] [Abstract][Full Text] [Related]
3. Low body mass index is an independent risk factor of locoregional recurrence in women with breast cancer undergoing breast conserving therapy.
Chen CH; Lo YF; Tsai HP; Shen SC; Chao TC; Chen MF; Chen SC
Chang Gung Med J; 2009; 32(5):553-62. PubMed ID: 19840513
[TBL] [Abstract][Full Text] [Related]
4. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
[TBL] [Abstract][Full Text] [Related]
6. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
7. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
8. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer.
Tanis E; van de Velde CJ; Bartelink H; van de Vijver MJ; Putter H; van der Hage JA
Eur J Cancer; 2012 Aug; 48(12):1751-6. PubMed ID: 22446021
[TBL] [Abstract][Full Text] [Related]
9. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.
Gabos Z; Thoms J; Ghosh S; Hanson J; Deschênes J; Sabri S; Abdulkarim B
Breast Cancer Res Treat; 2010 Nov; 124(1):187-94. PubMed ID: 20814819
[TBL] [Abstract][Full Text] [Related]
10. High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer.
Park CC; Rembert J; Chew K; Moore D; Kerlikowske K
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):75-9. PubMed ID: 18692323
[TBL] [Abstract][Full Text] [Related]
11. Body Mass Index and Outcomes in Breast Cancer Treated With Breast Conservation.
Patel V; James M; Frampton C; Robinson B; Davey V; Timmings L
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):369-376. PubMed ID: 31678226
[TBL] [Abstract][Full Text] [Related]
12. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
13. General and abdominal obesity and survival among young women with breast cancer.
Abrahamson PE; Gammon MD; Lund MJ; Flagg EW; Porter PL; Stevens J; Swanson CA; Brinton LA; Eley JW; Coates RJ
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1871-7. PubMed ID: 17035393
[TBL] [Abstract][Full Text] [Related]
14. Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study.
Elwood JM; Tin Tin S; Kuper-Hommel M; Lawrenson R; Campbell I
BMC Cancer; 2018 Jan; 18(1):76. PubMed ID: 29334917
[TBL] [Abstract][Full Text] [Related]
15. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
[TBL] [Abstract][Full Text] [Related]
16. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy.
Mirza NQ; Vlastos G; Meric F; Buchholz TA; Esnaola N; Singletary SE; Kuerer HM; Newman LA; Ames FC; Ross MI; Feig BW; Pollock RE; McNeese M; Strom E; Hunt KK
Ann Surg Oncol; 2002 Apr; 9(3):256-65. PubMed ID: 11923132
[TBL] [Abstract][Full Text] [Related]
17. Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
van Hezewijk M; Bastiaannet E; Putter H; Scholten AN; Liefers GJ; Rea D; Hasenburg A; Paridaens R; Hozumi Y; Markopoulos C; Seynaeve C; Jones SE; Marijnen CA; van de Velde CJ
Radiother Oncol; 2013 Aug; 108(2):190-6. PubMed ID: 24044798
[TBL] [Abstract][Full Text] [Related]
18. Body mass index and participation in organized mammographic screening: a prospective cohort study.
Hellmann SS; Njor SH; Lynge E; von Euler-Chelpin M; Olsen A; Tjønneland A; Vejborg I; Andersen ZJ
BMC Cancer; 2015 Apr; 15():294. PubMed ID: 25880028
[TBL] [Abstract][Full Text] [Related]
19. Obesity is associated with a poorer prognosis in women with hormone receptor positive breast cancer.
Robinson PJ; Bell RJ; Davis SR
Maturitas; 2014 Nov; 79(3):279-86. PubMed ID: 25088248
[TBL] [Abstract][Full Text] [Related]
20. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]